Albiglutide

Albiglutide

Summary

Albiglutide is a GLP-1 agonist used to manage type 2 diabetes mellitus.

Generic Name: Albiglutide

Background

Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is marketed under the brands Eperzan and Tanzeum by GSK (GlaxoSmithKline). It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin. Albiglutide was approved on April 15, 2014 by the FDA.

Protein Chemical Formula: C₃₂₃₂H₅₀₃₂N₈₆₄O₉₇₉S₄₁

Protein Average Weight: 72970.0 Da